The short answer
Cyclophosphamide is a chemotherapy and immune-suppressing drug that can, rarely, raise the risk of later leukemia and bladder cancer. Its benefits usually far outweigh this risk, and care teams monitor for it.
Cyclophosphamide is classified as a known human carcinogen (IARC Group 1).
People are mainly exposed by receiving it as prescribed chemotherapy or immune treatment.
It is most strongly linked to later leukemia and bladder cancer.
A carcinogen classification describes hazard — whether something can cause cancer — not your personal risk at a given exposure.
Choose how you want to understand this
The full explanation.
The simple version
Cyclophosphamide is a powerful drug used to treat some cancers and immune diseases. Because it works by damaging DNA in fast-growing cells, it can rarely cause a new cancer years later. For most people, the benefit of treating a serious illness far outweighs this small risk.
What cyclophosphamide is
Cyclophosphamide is an alkylating chemotherapy drug also used for some autoimmune conditions. The same DNA-damaging action that fights disease can, in a small number of people, contribute to a later cancer. It is classified as carcinogenic to humans for this reason.
How people are exposed
Common ways people come into contact with it:
- Receiving cyclophosphamide as chemotherapy or for an immune disease
- Higher cumulative doses carry more risk
- Given and monitored by a medical team
The cancer connection
Cyclophosphamide is linked to later acute leukemia and bladder cancer. Staying well hydrated during treatment and protective medications reduce bladder toxicity.
The International Agency for Research on Cancer (IARC), the cancer arm of the World Health Organization, places cyclophosphamide in Group 1, carcinogenic to humans — the strongest evidence category, meaning there is enough evidence that it can cause cancer in people. In the United States, the National Toxicology Program's Report on Carcinogens lists it as known to be a human carcinogen.
Hazard is not the same as risk
It helps to separate two ideas that are easy to mix up: hazard and risk. When an agency lists cyclophosphamide as a carcinogen, it is making a statement about hazard — whether the substance is capable of causing cancer under some conditions. It is not, by itself, a statement about your personal risk, which depends on how much you are exposed to, for how long, and other factors. Two substances in the same group can carry very different real-world risks. The label answers "can it cause cancer?" — not "how likely is it to cause cancer for me?"
How to lower your exposure
- Care teams use the lowest effective dose and monitor for late effects
- Protective medicines and hydration reduce bladder injury
- Follow-up care watches for any later blood or bladder problems
If you are looking at your overall cancer risk, small, steady steps add up. See our overview of cancer prevention and what raises cancer risk to put any single exposure in context.
The bottom line
Cyclophosphamide is a known human carcinogen (IARC Group 1). The most important thing you can do is understand where exposure comes from and take reasonable steps to reduce it, without losing sleep over a single label. Focus your energy on the biggest, most controllable risks in your own life.
Words to know
Tap any term to see what it means.
Common questions
▸Does cyclophosphamide cause cancer?
Yes. Cyclophosphamide is classified as a known human carcinogen, which means there is strong evidence it can cause cancer in people. How much any one person's risk rises depends on how much they are exposed to and for how long.
▸How are people exposed to cyclophosphamide?
Most exposure happens by receiving it as prescribed chemotherapy or immune treatment. This is a prescribed treatment; the decision to use it weighs treating a serious disease against a small later risk.
▸Which cancers are linked to cyclophosphamide?
It is most strongly linked to later leukemia and bladder cancer.
▸How can I reduce my exposure to cyclophosphamide?
The main steps are careful dosing, protective measures, and long-term follow-up.
▸Does a carcinogen label mean I will get cancer?
No. A classification is about hazard — whether cyclophosphamide can cause cancer under some conditions — not a prediction that any one exposed person will develop cancer. Your actual risk depends on the amount and length of exposure and other factors.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Test your knowledge
0 of 4 answered
This quiz checks understanding of educational content only. It is not medical advice. Open this quiz on its own page.